Literature DB >> 15574207

Radiotherapeutic factors in the management of cervical-basal chordomas and chondrosarcomas.

Georges Noël1, Loïc Feuvret, Régis Ferrand, Gilbert Boisserie, Jean-Jacques Mazeron, Jean-Louis Habrand.   

Abstract

OBJECTIVE: To define prognostic factors for local control and survival in 90 consecutive patients treated by fractionated photon and proton radiation for chordoma or chondrosarcoma of the cranial base and upper cervical spine.
METHODS: Between December 1995 and December 2000, 90 patients (median age, 51.3 yr; range, 10-85 yr; male/female ratio, 3:2) were treated by a combination of high-energy photons and protons. Sixty-four patients had a chordoma, and 26 had a chondrosarcoma. The proton component was delivered by the 201-MeV proton beam of the Centre de Protontherapie d'Orsay. The median total dose delivered to the gross tumor volume (GTV) was 67 cobalt Gray equivalents (range, 22-70 cobalt Gray equivalents).
RESULTS: With a median follow-up of 34 months (range, 3-74 mo), treatment of 25 tumors failed locally. The 3-year local control rates were 69.2% (+/-6.0%) and 91.6% (+/-8.4%) for chordomas and chondrosarcomas, respectively. According to multivariate analysis, a small tumor volume excluded from the 95% isodose line (P = 0.032; relative risk [RR], 0.098; 95% confidence interval [CI], 0.01-0.81) and a controlled tumor (P = 0.049; RR, 0.19; 95% CI, 0.04-0.99) were independent favorable prognostic factors for overall survival. On multivariate analysis, a high minimum dose (P = 0.02; RR, 2.8; 95% CI, 1.2-6.6), a high tumor control probability (P = 0.02; RR, 3.8; 95% CI, 1.2-12.5), a high dose delivered to 95% of the GTV (P = 0.03; RR, 3.4; 95% CI, 1.15-10.2), a high GTV encompassed by the 90% isodose line (P = 0.01; RR, 3.29; 95% CI, 1.29-8.44), and a small GTV excluded from the 90% isodose line (P = 0.036; RR, 0.4; 95% CI, 0.1-0.9) were independent favorable prognostic factors for local control.
CONCLUSION: In chordomas and chondrosarcomas of the cranial base and cervical spine treated by surgical resection and then by high-dose photon and proton irradiation, local control is mainly dependent on the quality of radiation, especially dose uniformity within the GTV. Special attention must be paid to minimize underdosed areas because of the close proximity of critical structures and to redefine and possibly escalate dose constraints to tumor targets in future studies in view of the low toxicity observed to date.

Entities:  

Mesh:

Year:  2004        PMID: 15574207     DOI: 10.1227/01.neu.0000143330.30405.aa

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  20 in total

1.  Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute.

Authors:  Damien C Weber; Shahed Badiyan; Robert Malyapa; Francesca Albertini; Alessandra Bolsi; Antony J Lomax; Ralf Schneider
Journal:  Neuro Oncol       Date:  2015-08-30       Impact factor: 12.300

2.  Multilevel oblique corpectomies as an effective surgical option to treat cervical chordoma in a young girl.

Authors:  Roberto Delfini; Daniele Marruzzo; Roberto Tarantino; Nicola Marotta; Alessandro Landi
Journal:  World J Clin Cases       Date:  2014-03-16       Impact factor: 1.337

3.  PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.

Authors:  Wei Liu; Steven J Frank; Xiaoqiang Li; Yupeng Li; Ron X Zhu; Radhe Mohan
Journal:  Med Phys       Date:  2013-02       Impact factor: 4.071

4.  Hyperfractionated high-dose proton beam radiotherapy for clival chordomas after surgical removal.

Authors:  Yasutaka Hayashi; Masashi Mizumoto; Hiroyoshi Akutsu; Shingo Takano; Akira Matsumura; Toshiyuki Okumura; Takuya Kawabe; Junko Zenkoh; Hideyuki Sakurai; Koji Tsuboi
Journal:  Br J Radiol       Date:  2016-04-21       Impact factor: 3.039

5.  Stereotactic radiosurgery for primary and metastatic sarcomas involving the spine.

Authors:  U K Chang; W I Cho; D H Lee; M S Kim; C K Cho; S Y Lee; D G Jeon
Journal:  J Neurooncol       Date:  2012-01-15       Impact factor: 4.130

6.  Proton beam radiotherapy: report of the first ten patients treated at the "Centro Nazionale di Adroterapia Oncologica (CNAO)" for skull base and spine tumours.

Authors:  Roberto Orecchia; Viviana Vitolo; Maria Rosaria Fiore; Piero Fossati; Alberto Iannalfi; Barbara Vischioni; Anurita Srivastava; Jeffrey Tuan; Mario Ciocca; Silvia Molinelli; Alfredo Mirandola; Gloria Vilches; Andrea Mairani; Barbara Tagaste; Marco Riboldi; Giulia Fontana; Guido Baroni; Sandro Rossi; Marco Krengli
Journal:  Radiol Med       Date:  2013-12-12       Impact factor: 3.469

7.  Dosimetric benefits of robust treatment planning for intensity modulated proton therapy for base-of-skull cancers.

Authors:  Wei Liu; Radhe Mohan; Peter Park; Zhong Liu; Heng Li; Xiaoqiang Li; Yupeng Li; Richard Wu; Narayan Sahoo; Lei Dong; X Ronald Zhu; David R Grosshans
Journal:  Pract Radiat Oncol       Date:  2014-01-14

Review 8.  The clinical management of chondrosarcoma.

Authors:  Richard F Riedel; Nicole Larrier; Leslie Dodd; David Kirsch; Salutario Martinez; Brian E Brigman
Journal:  Curr Treat Options Oncol       Date:  2009-02-24

Review 9.  A systematic review of proton therapy in the treatment of chondrosarcoma of the skull base.

Authors:  Maurizio Amichetti; Dante Amelio; Marco Cianchetti; Riccardo Maurizi Enrici; Giuseppe Minniti
Journal:  Neurosurg Rev       Date:  2010-04       Impact factor: 3.042

10.  Chordomas and chondrosarcomas of the skull base: comparative analysis of clinical results in 30 patients.

Authors:  Young Hyun Cho; Jeong Hoon Kim; Shin Kwang Khang; Jung-Kyo Lee; Chang Jin Kim
Journal:  Neurosurg Rev       Date:  2007-10-09       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.